MRC1 and neoplasm: However, to initiate tumorigenesis, both copies of the gene must be dysfunctional in the tumor cells, meaning a second genetic alteration must occur in the remaining healthy allele, leading to loss of heterozygosity (typically through somatic, acquired changes), resulting in complete loss of MMR protein expression in the tumor.